These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 3812772)

  • 1. Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.
    Shillabeer G; Davison JS
    Am J Physiol; 1987 Feb; 252(2 Pt 2):R353-60. PubMed ID: 3812772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous and exogenous cholecystokinin may reduce food intake by different mechanisms.
    Shillabeer G; Davison JS
    Am J Physiol; 1987 Aug; 253(2 Pt 2):R379-82. PubMed ID: 3618836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans.
    Konturek SJ; Kwiecien N; Obtulowicz W; Kopp B; Oleksy J; Rovati L
    Digestion; 1990; 45(1):1-8. PubMed ID: 2340960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
    Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
    Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of vagotomy on the increase in food intake induced by the cholecystokinin antagonist, proglumide.
    Shillabeer G; Davison JS
    Regul Pept; 1985 Oct; 12(2):91-9. PubMed ID: 4070688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cholecystokinin antagonist, proglumide, increases food intake in the rat.
    Shillabeer G; Davison JS
    Regul Pept; 1984 Apr; 8(3):171-6. PubMed ID: 6463283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proglumide fails to increase food intake after an ingested preload.
    Schneider LH; Gibbs J; Smith GP
    Peptides; 1986; 7(1):135-40. PubMed ID: 3714531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological role of cholecystokinin on gastric emptying and acid output in dogs.
    Jin HO; Lee KY; Chang TM; Chey WY; Dubois A
    Dig Dis Sci; 1994 Nov; 39(11):2306-14. PubMed ID: 7956596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo.
    Scarpignato C; Kisfalvi I; D'Amato M; Varga G
    Aliment Pharmacol Ther; 1996 Jun; 10(3):411-9. PubMed ID: 8791971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
    Corazziari E; Ricci R; Biliotti D; Bontempo I; De Medici A; Pallotta N; Torsoli A
    Dig Dis Sci; 1990 Jan; 35(1):50-4. PubMed ID: 2295294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats.
    Wu CL; Hung CR; Chang FY; Pau KY; Wang PS
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):406-13. PubMed ID: 12690433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients.
    Konturek JW; Thor P; Maczka M; Stoll R; Domschke W; Konturek SJ
    Scand J Gastroenterol; 1994 Jul; 29(7):583-90. PubMed ID: 7939393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of satiety by a cholecystokinin antagonist is independent of gastric emptying.
    Collins SM; Weingarten HP
    Peptides; 1984; 5(3):481-4. PubMed ID: 6089141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
    Watkins LR; Kinscheck IB; Mayer DJ
    Brain Res; 1985 Feb; 327(1-2):169-80. PubMed ID: 3838690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of juice from Morinda citrifolia (Noni) on gastric emptying in male rats.
    Pu HF; Huang WJ; Tseng WM; Wang SW; Liu YW; Doong ML; Wang PS
    Chin J Physiol; 2004 Dec; 47(4):169-74. PubMed ID: 15803749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholecystokinin on gastric motility in humans.
    Beglinger C
    Ann N Y Acad Sci; 1994 Mar; 713():219-25. PubMed ID: 8185162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the cholecystokinin antagonist, proglumide, on prolactin secretion in the rat.
    Vijayan E; McCann SM
    Life Sci; 1987 Feb; 40(7):629-34. PubMed ID: 3807652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of gastric emptying and intestinal transit by amphetamine through a mechanism involving an increased secretion of CCK in male rats.
    Doong ML; Lu CC; Kau MM; Tsai SC; Chiao YC; Chen JJ; Yeh JY; Lin H; Huang SW; Chen TS; Chang FY; Wang PS
    Br J Pharmacol; 1998 Jul; 124(6):1123-30. PubMed ID: 9720782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.